Vanguard Group Inc Abbott Laboratories Transaction History

Vanguard Group Inc

$5.46 Trillion
Q3 2024

A detailed history of Vanguard Group Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Vanguard Group Inc holds 167,906,137 shares of ABT stock, worth $19.2 Billion. This represents 0.35% of its overall portfolio holdings.

Number of Shares

167,906,137

Previous 166,353,894 0.93%

Holding current value

$19.2 Billion

Previous $17.3 Billion 10.74%

% of portfolio

0.35%

Previous 0.34%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$100.07 - $118.13 $155 Million - $183 Million	1,552,243 Added 0.93%	167,906,137 $19.1 Billion
Q2 2024 Aug 13, 2024	BUY	$100.73 - $112.44 $106 Million - $118 Million	1,051,973 Added 0.64%	166,353,894 $17.3 Billion
Q1 2024 May 10, 2024	BUY	$109.52 - $120.96 $968 Million - $1.07 Billion	8,834,840 Added 5.65%	165,301,921 $18.8 Billion
Q4 2023 Mar 11, 2024	BUY	$90.19 - $110.4 $2.02 Million - $2.47 Million	22,381 Added 0.01%	156,467,081 $17.2 Billion
Q4 2023 Feb 14, 2024	BUY	$90.19 - $110.4 $61.3 Million - $75 Million	679,359 Added 0.44%	156,444,700 $17.2 Billion
Q3 2023 Nov 14, 2023	BUY	$95.53 - $114.62 $2.68 Million - $3.22 Million	28,065 Added 0.02%	155,765,341 $15.1 Billion
Q2 2023 Aug 14, 2023	BUY	$100.78 - $112.29 $9.65 Million - $10.8 Million	95,767 Added 0.06%	155,737,276 $17 Billion
Q1 2023 Jul 14, 2023	BUY	$96.86 - $114.01 $1.51 Million - $1.78 Million	15,605 Added 0.01%	155,641,509 $15.8 Billion
Q1 2023 May 15, 2023	BUY	$96.86 - $114.01 $14.1 Million - $16.5 Million	145,110 Added 0.09%	155,625,904 $15.8 Billion
Q4 2022 Feb 10, 2023	BUY	$95.06 - $111.52 $87.2 Million - $102 Million	917,373 Added 0.59%	155,480,794 $17.1 Billion
Q3 2022 Nov 14, 2022	BUY	$96.76 - $112.03 $195 Million - $225 Million	2,011,683 Added 1.32%	154,563,421 $15 Billion
Q2 2022 Aug 12, 2022	BUY	$102.07 - $123.37 $129 Million - $156 Million	1,263,297 Added 0.84%	152,551,738 $16.6 Billion
Q1 2022 May 13, 2022	BUY	$114.02 - $139.04 $244 Million - $297 Million	2,136,177 Added 1.43%	151,288,441 $17.9 Billion
Q4 2021 Feb 14, 2022	BUY	$115.53 - $141.46 $43 Million - $52.7 Million	372,318 Added 0.25%	149,152,264 $21 Billion
Q3 2021 Nov 12, 2021	BUY	$116.66 - $129.06 $109 Million - $121 Million	935,362 Added 0.63%	148,779,946 $17.6 Billion
Q2 2021 Aug 13, 2021	BUY	$105.79 - $124.53 $15.6 Billion - $18.4 Billion	147,844,584 New	147,844,584 $17.1 Billion

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $200B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Abbott Laboratories Transaction History